Check your heart risk earlier —
through your eyes

Dr. Noon CVD is a simple screening exam that uses a retinal image (a photo of the back of your eye)
to estimate cardiovascular risk. Your retina contains tiny blood vessels, and subtle changes in these vessels
can offer early clues about your overall vascular health, often before you notice any symptoms. (1)(2)

How It Works

Why the retina
matters

The retina is the only place in the body where blood vessels can be viewed directly in a simple, non-invasive way.

Because these small vessels can reflect changes happening throughout the body, a retinal image may reveal risk signals that would otherwise be hard to see early on. (1)(2)(3)(4)(5)

The retina is the window to systemic vascular health.
We can find early clues about our overall vascular health,
often before we notice any symptoms.

Clinical Validation

Why you can trust
this exam

The retina does more than help you see. It also contains tiny blood vessels that reflect how your vascular system is doing overall. Since these vessels can be photographed easily and safely, doctors and researchers have long studied the retina as a helpful window into whole-body health. (1)(3)(4)(5)

Dr. Noon CVD uses this medical insight to look for patterns linked to cardiovascular risk, and this approach is supported by clinical validation studies and published research showing that retinal images can help predict cardiovascular risk factors and related outcomes. (2)(6)(7)(8)(9)

It provides a non-invasive, needle-and-radiation-free exam experience with clear, actionable results. Officially authorized as a medical device across nine global regions—including Europe (CE), the UK, Australia, Brazil, South Korea, Singapore, Malaysia, Thailand, and Indonesia—it is actively used in clinical practice worldwide.

Validated Performance

Performance
comparable to
cardiac CT

Dr. Noon CVD’s predictive performance has been clinically validated against cardiac CT. Using large-scale retinal image data, the exam analyzes the structures and blood vessels in the retina to estimate the risk of cardiovascular events such as heart attack, stroke, and heart failure. (10)

REVIEW YOUR RESULTS

Understand what your results mean

Your report is designed to be clear and easy to understand, so you can better review your results and feel more prepared for discussions about next steps.

  • It is designed to be easy to read and act on, with clear guidance on what your result may mean for your health.

  • It places your score in context by age group, showing where you stand and why prevention matters more as risk increases with age.

  • It shows where your score falls among people of similar age and sex, offering a helpful reference rather than a diagnosis.

  • It highlights lifestyle factors like activity, sleep, and weight, giving your doctor a fuller picture of your heart health beyond the score alone.

See how the test is done

References

  1. Retinal vessel diameters and function in cardiovascular risk and disease. Progress in Retinal and Eye Research (2022).
  2. Standardization and clinical applications of retinal imaging biomarkers for cardiovascular and neurovascular diseases. Nature Reviews Cardiology (2024).
  3. The eye as a window to systemic health: A survey of retinal imaging from classical techniques to oculomics. Preventive Medicine Reports (2025).
  4. The Use of Retinal Imaging Including Fundoscopy, OCT, and OCTA for Cardiovascular Risk Stratification and the Detection of Subclinical Atherosclerosis. Current Atherosclerosis Reports (2025).
  5. Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning. Nature Biomedical Engineering (2018).
  6. Predicting Cardiovascular Risk Factors in Retinal Fundus Photographs using Deep Learning. Google Research publication page / pre-publication version.
  7. Prediction of cardiovascular markers and diseases using retinal fundus images and deep learning: a systematic scoping review. European Heart Journal - Digital Health (2024).
  8. Validation of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease. BMC Medicine (2023).
  9. Through the eye to the heart: a scoping review of artificial intelligence in retinal imaging for cardiovascular disease assessment. BMC Medical Informatics and Decision Making (2025).
  10. Pivotal trial of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from CMERC-HI. JAMIA (October 2023)